Clinical Study on Yishen Wendu Compound in Treatment of Ankylosing Spondylitis of Kidney Deficiency and Cold Governor Vessel Type / 中国中医药信息杂志

Objective To study the clinical effect and safety of Yishen Wendu Compound in treatment of ankylosing spondylitis (AS) of kidney deficiency and cold governor vessel type. Methods The diversification of the clinical symptoms, signs and laboratory indicators of ankylosing spondylitis patients in Yishen Wendu Compound 30 cases of treatment group and sulfasalazine (SASP) 30 cases of control group before and after treatment were observed. Results After treatment, the percentage of ASAS20 standard cases number (%) and the efficacy of TCM syndrome total effective rates of treatment group were 95.83% and 93.3% respectively, superior to sulfasalazine control group 82.5% and 66.7% (P